Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 8—August 2007

Dispatch

Molecular Epidemiology of Canine Parvovirus, Europe

Nicola Decaro*Comments to Author , Costantina Desario*, Diane D. Addie†, Vito Martella*, Maria João Vieira‡, Gabriella Elia*, Angelique Zicola§, Christopher Davis†, Gertrude Thompson‡, Ethienne Thiry§, Uwe Truyen¶, and Canio Buonavoglia*
Author affiliations: *University of Bari, Bari, Italy; †University of Glasgow, Glasgow, Scotland, UK; ‡University of Porto, Porto, Portugal; §University of Liege, Liege, Belgium; ¶University of Leipzig, Leipzig, Germany;

Main Article

Figure

Geographic distribution of antigenic variants of canine parvovirus (CPV) in Europe. CPV-positive fecal samples or viral isolates from different countries were analyzed by molecular methods; strains CPV-2, 2a, 2b, or 2c are indicated for each country by numbers in parentheses. Samples were collected during 2005–2006, except for samples from Italy (2006) and Germany (1996–2005). P, Portugal; S, Spain; UK, United Kingdom; B, Belgium; CH, Switzerland; D, Germany; CZ, Czech Republic.

Figure. Geographic distribution of antigenic variants of canine parvovirus (CPV) in Europe. CPV-positive fecal samples or viral isolates from different countries were analyzed by molecular methods; strains CPV-2, 2a, 2b, or 2c are indicated for each country by numbers in parentheses. Samples were collected during 2005–2006, except for samples from Italy (2006) and Germany (1996–2005). P, Portugal; S, Spain; UK, United Kingdom; B, Belgium; CH, Switzerland; D, Germany; CZ, Czech Republic.

Main Article

TOP